Kedrion Biopharma UK

Kedrion Biopharma UK

3y

Bio Products Laboratory USA, Inc. is thrilled to be selected by Triangle Business Journal as a Best Place to Work! We strive for our small but mighty company to be the best inside and out, and that starts with our employees. Without them, we would not be able to do what we do! ...Show more

Kedrion Biopharma UK

3y

Permira Funds & the Marcucci Family Complete Kedrion-BPL Investment We are pleased to share that the Permira funds, in partnership with the Marcucci family, have completed the joint acquisition and combination of Kedrion Biopharma and Bio Products Laboratory Limited (BPL). Ugo Di Francesco, CEO of Chiesi Group, has been appointed the new CEO of the combined company, effective January 2023. The combination of BPL and Kedrion creates a global player for medicinal products derived from human blood plasma, which treat patients with rare and life-threatening conditions....Show more

Kedrion Biopharma UK

3y

BPL’s Peace Garden opened during our Wellbeing Event After many hours of work, come rain or shine, the BPL Peace Garden has been officially opened within our Elstree site. The Peace Garden is a historic part of our Elstree site, originally used in 1850’s for pioneering research and development. Now fully redesigned; housing an array of seating areas, duck and bird houses and many beautiful plants, to give our colleagues a space for quiet contemplation and moments of calm. Utilising the power that nature has on our mental health and wellbeing. Thank all our wonderful colleague volunteers and contributors for all their time and hard work on making and maintaining the Peace Garden ...Show more

Kedrion Biopharma UK

3y

We are very excited to be attending and participating at the International Society on Thrombosis and Haemostasis (ISTH) Congress from this weekend (9-13 July), where we will sponsor an independent medical presentation on rare bleeding disorder therapies during a product theatre targeted for healthcare professionals. The event brings together thousands of the world’s leading experts in the field of thrombosis, haemostasis, and vascular biology to present the most recent advances, exchange the latest science and discuss the newest clinical applications designed to improve patient care. By engaging with these experts and working alongside healthcare professionals, we will continue raising awareness and supporting people in the plasma-derived therapy community worldwide. As part of our commitment to patients, BPL supports the ongoing development of innovative medicines for the world’s rarest conditions...Show more

Kedrion Biopharma UK

3y

BPL are pleased to share that we are in the May Issue of Manufacturing Today. Manufacturing Today is one of the must-read trade publications for industry leaders. Through its print and digital publications and online presence, Manufacturing Today helps executives at the senior boardroom and production levels stay abreast of the most important operational issues in this dynamic market. Manufacturing Today is all about championing the future for all manufacturers and their supply chains, addressing the needs of manufacturers and aims to help them today’s climate. The article shares the history of BPL, from its infancy within the Lister Institute to our present form as part of BPL Holding Limited, giving readers an insight to the recent growth in international markets, the recently granted licence to market Albuminex® to China, and our first ever direct sales to Mexico. The article also briefly explores our efficiency improvements, the recent US patent process for extracting Immunoglobulin and the works we have all done to improve yield across the business, the focus on training and ...Show more